Assuntos
Piomiosite/diagnóstico , Infecções Estafilocócicas/diagnóstico , Adolescente , Antibacterianos/administração & dosagem , Cloxacilina/administração & dosagem , Humanos , Pulmão/diagnóstico por imagem , Pulmão/patologia , Imageamento por Ressonância Magnética , Masculino , Músculo Esquelético/microbiologia , Piomiosite/tratamento farmacológico , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus/isolamento & purificação , Tomografia Computadorizada por Raios XRESUMO
El impétigo ampolloso o bulloso es una enfermedad infectocontagiosa de la piel, causada por Staphylococcus aureus y mediada por toxina. Se caracteriza por la aparición de ampollas flácidas sobre lesiones vesiculares iniciales. Es importante el diagnóstico diferencial en estadios iniciales con otras patologías que cursan con lesiones vesiculosas, como la varicela. La elección del tratamiento se basa en la extensión, localización y profundidad de las lesiones, utilizando siempre antibioterapia contra S. aureus y comprobando la sensibilidad antibiótica debido a la creciente prevalencia de S. aureus resistente a la meticilina (SARM) (AU)
Bullous impetigo is an infectious-contagious skin disease toxin-mediated, caused by Staphylococcus aureus. Its characterized by the appearance of flaccid blisters on initial vesicular lesions. Its important the differential diagnosis with other diseases involving vesicular lesions, such as chickenpox in early stages. The choice of treatment is based on the extent, location and depth of the lesions, always using antibiotic therapy against S. aureus and checking antibiotic sensitivity due to the increasing prevalence of MRSA (methicillin resistant S. aureus) (AU)
Assuntos
Humanos , Masculino , Pré-Escolar , Impetigo/diagnóstico , Impetigo/tratamento farmacológico , Cloxacilina/administração & dosagem , Antibacterianos/administração & dosagem , Diagnóstico DiferencialRESUMO
OBJECTIVES: To describe the efficacy and safety of prolonged cefazolin course for Staphylococcus infection and the emergence of multidrug-resistant bacteria carriage after treatment. METHODS: Monocentric retrospective cohort study of patients hospitalized for blood stream infections (BSI) and osteoarticular infections (OAI) by methicillin susceptible staphylococcal species treated with cefazolin from January 2015 to July 2017. Rectal and nasal swabs were performed at cefazolin initiation and end of treatment to detect respectively methicillin resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) producing bacteria. RESULTS: Fifty-eight patients were included, 41 had a bacteremia including 22 endocarditis and 22 OAI. Mean duration of treatment was 21.5 days at a mean daily dose of 6.5g/d. Fifty-five (94.5%) received combination therapy. Fifty-two (89.7%) of patients achieved bacteriological cure. Four patients were ESBL carriers at inclusion. No additional ESBL or MRSA were detected by end of treatment. CONCLUSION: Cefazolin appears as an effective and safe treatment for BSI or osteoarticular infection and does not appear to select MRSA or ESBL.
Assuntos
Antibacterianos/administração & dosagem , Cefazolina/administração & dosagem , Farmacorresistência Bacteriana Múltipla , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Infecções Estafilocócicas/tratamento farmacológico , Idoso , Bacteriemia/tratamento farmacológico , Doenças Ósseas Infecciosas/tratamento farmacológico , Enterobacteriáceas Resistentes a Carbapenêmicos/efeitos dos fármacos , Enterobacteriáceas Resistentes a Carbapenêmicos/isolamento & purificação , Cloxacilina/administração & dosagem , Endocardite Bacteriana/tratamento farmacológico , Feminino , Humanos , Masculino , Meticilina/uso terapêutico , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Pessoa de Meia-Idade , Estudos Retrospectivos , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/isolamento & purificaçãoRESUMO
BACKGROUND: The evidence supporting rifampin combination therapy in prosthetic joint infections (PJI) is limited due to the lack of controlled studies. The aim of this study is to evaluate the effect of adding rifampin to conventional antimicrobial therapy in early staphylococcal PJIs treated with debridement and retention of the implant (DAIR). METHODS: In this multicenter randomized controlled trial, 99 patients with PJI after hip and knee arthroplasties were enrolled. They were randomly assigned to receive rifampin or not in addition to standard antimicrobial treatment with cloxacillin or vancomycin in case of methicillin resistance. The primary endpoint was no signs of infection after 2 years of follow-up. RESULTS: Forty-eight patients were included in the final analyses. There were no differences in patient characteristics or comorbidities between the two groups. There was no significant difference in remission rate between the rifampin combination group (17 of 23 (74%)) and the monotherapy group (18 of 25 (72%), relative risk 1.03, 95% confidence interval 0.73 to 1.45, p = 0.88). CONCLUSION: This trial has not proven a statistically significant advantage by adding rifampin to standard antibiotic treatment in acute staphylococcal PJIs. TRIAL REGISTRATION: The Regional Ethics Committee and the Norwegian Medicines Agency approved the study (EudraCT 2005-005494-29), and the study was registered at ClinicalTrials.gov at Jan 18, 2007 ( NCT00423982 ).
Assuntos
Antibacterianos/administração & dosagem , Infecções Relacionadas à Prótese/tratamento farmacológico , Rifampina/administração & dosagem , Infecções Estafilocócicas/tratamento farmacológico , Adulto , Idoso , Idoso de 80 Anos ou mais , Cloxacilina/administração & dosagem , Desbridamento , Quimioterapia Combinada , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Resultado do Tratamento , Vancomicina/administração & dosagemRESUMO
BACKGROUND: Mastitis is one of the most costly diseases in Mediterranean buffalo (MB). At present, just a few specific antibiotics registered for this dairy specie have been synthetized. Efficacy of an antibiotic dry buffalo therapy (aDBT) against Staphylococcus aureus (S. aureus) mastitis, based on intra-quarter administration of 600 mg of benzathine cloxacillin, have been evaluated for the first time. Eighty MB's quarters received a drying-off therapy (aDBT-group) and 80 were left untreated (no-aDBT-group). They were sampled at drying-off (pre-treatment) and at the resumption of milking [< 10 days in milk (DIM)]. Fresh calver mastitis rate, dry period new mastitis rate, dry period cure rate, and persistent mastitis rate were calculated for clinical monitoring. Overall proportion of positive quarters/animals, quarters affected by mastitis or intramammary infections (IMI), effects on somatic cell count (SCC) and milk yield were also assessed. RESULTS: An inter-group difference (aDBT vs. no-aDBT) was recorded for all the indexes considered. An intra-group (drying-off vs. < 10 DIM) difference was detected in aDBT-group regarding the proportion of positive-cultured quarters and animals. Concerning the latter, an inter-groups difference was also recorded at second sampling. No clinical mastitis due to the S. aureus was observed. Regarding the subclinical ones, a higher intra-group difference was observed in aDBT than no-aDBT group, while an inter-group difference was recorded at second sampling. No protective effect was observed against IMI. SCC showed an inter-group difference at second sampling, while none difference was instead detected for milk yield. CONCLUSIONS: The effects against S. aureus mastitis of benzathine cloxacillin administration at drying-off were assessed for the first time in MB. Its use shows encouraging results in reducing the proportion of mastitis and positive animals at the resumption of the lactation.
Assuntos
Antibacterianos/uso terapêutico , Búfalos , Cloxacilina/análogos & derivados , Mastite/veterinária , Infecções Estafilocócicas/veterinária , Animais , Antibacterianos/administração & dosagem , Bovinos , Cloxacilina/administração & dosagem , Cloxacilina/uso terapêutico , Indústria de Laticínios , Feminino , Itália , Lactação , Mastite/tratamento farmacológico , Leite/estatística & dados numéricos , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus/efeitos dos fármacosRESUMO
Infections of the subscapular space are very infrequent entities, which is why their diagnosis (for which it is crucial to carry out magnetic resonance imaging or, failing that, computerized tomography) can prove complicated. This difficulty in making the diagnosis conditions the speed of treatment (surgical draining that can be accompanied by antibiotherapy), which is crucial for the medium and long-term prognosis. We present the case of a patient who developed a spontaneous subscapular abscess that was drained using a delto-pectoral approach, with the subscapular space accessed via a medial route to the coracoids. The relevance of this case lies in its singular character and in the description of an approach that has only been used in two prior cases in the literature
Las infecciones del espacio subescapular son entidades muy poco frecuentes y, por ello, su diagnóstico (para el que resulta clave la realización de una resonancia magnética o, en su defecto, una tomografía computarizada) puede resultar complicado. Esta dificultad en el diagnóstico condiciona la rapidez en el tratamiento (drenaje quirúrgico acompañado o no de antibioterapia), que resulta clave para el pronóstico a medio y largo plazo. Presentamos el caso de un paciente que desarrolló un absceso subescapular espontáneo que se drenó mediante un abordaje delto-pectoral, accediendo al espacio subescapular por vía medial a la coracoides. La relevancia del caso presentado radica en su singularidad y en la descripción de una vía de abordaje que solo ha sido empleada en dos casos previos en la literatura
Assuntos
Humanos , Masculino , Adulto , Manguito Rotador/diagnóstico por imagem , Manguito Rotador/patologia , Abscesso/cirurgia , Infecções dos Tecidos Moles/cirurgia , Manguito Rotador/cirurgia , Abscesso/diagnóstico por imagem , Infecções dos Tecidos Moles/diagnóstico por imagem , Infecções dos Tecidos Moles/tratamento farmacológico , Espectroscopia de Ressonância Magnética , Infecções dos Tecidos Moles/microbiologia , Cloxacilina/administração & dosagem , Levofloxacino/administração & dosagemRESUMO
La osteomielitis pélvica asociada a infección del músculo obturador interno es una infección poco difundida en la literatura científica. Presentamos el caso de un adolescente con ambas infecciones y una revisión del abordaje terapéutico de ambas patologías
Pelvic osteomyelitis associated with pyomyositis of the obturador internus muscle is rarely reported. We present the case of a teenager with both infections and a review of the therapeutic approach of both pathologies
Assuntos
Humanos , Masculino , Adolescente , Piomiosite/diagnóstico , Piomiosite/complicações , Osteomielite/complicações , Osteomielite/diagnóstico , Osteomielite/tratamento farmacológico , Piomiosite/tratamento farmacológico , Cintilografia , Imageamento por Ressonância Magnética , Punções , Tomografia Computadorizada por Raios X , Antibacterianos/administração & dosagem , Cefotaxima/administração & dosagem , Cloxacilina/administração & dosagemRESUMO
Chronically infected diabetic wounds have a polymicrobial aetiology. However, Salmonella Paratyphi A is a very rare cause of wound infection. A 76-year-old female patient with type II diabetes presented with a wound on the left leg of two months' duration. The wound was painful, erythematous and a thick, foul-smelling discharge was present. There was a history of delayed wound healing. Salmonella Paratyphi A and Pseudomonas aeruginosa were isolated from the wound tissue. The patient was treated with cefuroxime and cloxacillin empirically and following the antibiotic susceptibility testing (ABST) report, ciprofloxacin was given for 10 days. The wound was treated with multiple debridements and topical antiseptic. On follow-up, the patient remained afebrile with subsiding discharge from the ulcer. This is the first reported case of Salmonella Paratyphi A from an infected diabetic ulcer in Sri Lanka and it serves to further define the spectrum of illnesses caused by this uncommon pathogen.
Assuntos
Antibacterianos/administração & dosagem , Ciprofloxacina/administração & dosagem , Diabetes Mellitus Tipo 2/complicações , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Úlcera da Perna/microbiologia , Salmonella paratyphi A/isolamento & purificação , Idoso , Anti-Infecciosos Locais/administração & dosagem , Cefuroxima/administração & dosagem , Cloxacilina/administração & dosagem , Desbridamento , Feminino , Infecções por Bactérias Gram-Negativas/etiologia , Infecções por Bactérias Gram-Negativas/microbiologia , Humanos , Úlcera da Perna/etiologia , Úlcera da Perna/fisiopatologia , Testes de Sensibilidade Microbiana , Febre Paratifoide/tratamento farmacológico , Febre Paratifoide/etiologia , Febre Paratifoide/microbiologia , Infecções por Pseudomonas/tratamento farmacológico , Infecções por Pseudomonas/etiologia , Infecções por Pseudomonas/microbiologia , Pseudomonas aeruginosa/isolamento & purificação , Salmonella paratyphi A/efeitos dos fármacos , CicatrizaçãoRESUMO
No disponible
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Doenças Transmitidas por Carrapatos/complicações , Rickettsia conorii/patogenicidade , Doença Enxerto-Hospedeiro/diagnóstico , Doença Enxerto-Hospedeiro/parasitologia , Exantema/diagnóstico , Rickettsia conorii/efeitos dos fármacos , Cloxacilina/administração & dosagem , Exantema/tratamento farmacológico , Metilprednisolona/administração & dosagem , Ciclosporina/administração & dosagemRESUMO
BACKGROUND: Bacteremia following Staphylococcus aureus is a serious clinical condition which is often associated with distant metastatic infections. One of the most dreaded complications of Staphylococcus aureus bacteremia is infective endocarditis. Cloxacillin is a common antibiotic prescribed for suspected staphylococcal infections and confirmed methicillin-sensitive Staphylococcus aureus infections. Prolonged use of cloxacillin may lead to neutropenia. CASE PRESENTATION: A 38-year-old Sinhalese man presented to Teaching Hospital Kurunegala, Sri Lanka, complaining of a 3-week history of fever; he was found to have a pansystolic murmur over the apex of his heart. He had leukocytosis with predominant neutrocytosis. His C-reactive protein was 231 mg/l and erythrocyte sedimentation rate was 100 mm/first hour. Transthoracic two-dimensional echocardiography revealed prolapsed mitral valve with 7 × 13 mm vegetation over the posterior mitral valve. On the following day, three blood cultures became positive and were subsequently identified as Staphylococcus aureus. Intravenously administered cloxacillin 3 g 6 hourly was started. Following day 24 of intravenously administered cloxacillin, our patient developed high spike fever. His total white blood cells were: 990/mm3 with 34% neutrophils and 22% eosinophils. His hemoglobin concentration was 9.5 g/dL and platelet count remained normal (202 × 106/mm3). His C-reactive protein was 78 mg/l, erythrocyte sedimentation rate was 95 mm/first hour, and he was otherwise comfortable, showing no signs of sepsis beside the high grade fever. His serum was negative for filarial and Toxoplasma antibodies while stool was negative for oocytes and amoebic cysts. Further, his serum was negative for dengue virus, Epstein-Barr virus, cytomegalovirus, and hepatitis B antibodies. He was clinically well on day 6 after stopping cloxacillin with 44% neutrophils and 18% eosinophils. His C-reactive protein and erythrocyte sedimentation rate became normal, and there was no further plan for cardiothoracic intervention or administration of antimicrobials. He was discharged from hospital and remained well 6 months later. CONCLUSION: This case report signifies the potential fatal adverse effect of cloxacillin in methicillin-sensitive Staphylococcus aureus infections. Leukopenia is associated with prolonged use of high doses of cloxacillin. In addition to transthoracic two-dimensional echocardiography and inflammatory markers, sequential white blood cells and differential counts would help clinicians to assess the prognosis of patients with infective endocarditis.
Assuntos
Antibacterianos/administração & dosagem , Cloxacilina/administração & dosagem , Endocardite Bacteriana/tratamento farmacológico , Eosinofilia/induzido quimicamente , Neutropenia/induzido quimicamente , Infecções Estafilocócicas/tratamento farmacológico , Administração Intravenosa , Adulto , Antibacterianos/efeitos adversos , Cloxacilina/efeitos adversos , Ecocardiografia Transesofagiana , Endocardite Bacteriana/diagnóstico , Fadiga , Febre , Humanos , Masculino , Valva Mitral/patologia , Infecções Estafilocócicas/diagnóstico , Resultado do TratamentoAssuntos
Valva Aórtica/efeitos dos fármacos , Valva Aórtica/patologia , Ciprofloxacina/uso terapêutico , Doenças das Valvas Cardíacas/induzido quimicamente , Idoso , Artroplastia do Joelho/efeitos adversos , Cloxacilina/administração & dosagem , Colágeno/química , Fluoroquinolonas/farmacologia , Humanos , Masculino , Infecções Relacionadas à Prótese , Rifampina/administração & dosagem , TendinopatiaRESUMO
WHAT IS KNOWN AND OBJECTIVE: Beta-lactam antibiotic (BLA) therapy is frequently needed to treat infective endocarditis (IE). Hypersensitive reactions to BLA restrict BLA therapy in allergic patients. In the current case, we aim to describe the utility of desensitization (DS) in this context. Although the evidence is limited, DS is recommended. CASE DESCRIPTION: This case report deals with a 79-year-old woman with a clinical suspicion of allergy to BLA and a methicillin-sensitive Staphylococcus aureus (MSSA) IE. A cloxacillin DS protocol was developed to enable treatment with cloxacillin. WHAT IS NEW AND CONCLUSION: Alternative antibiotic treatments may be less effective or not available in MSSA IE. In this case report, DS allowed optimal cloxacillin treatment.
Assuntos
Antibacterianos/administração & dosagem , Cloxacilina/administração & dosagem , Endocardite Bacteriana/tratamento farmacológico , Infecções Estafilocócicas/tratamento farmacológico , Idoso , Antibacterianos/efeitos adversos , Antibacterianos/imunologia , Cloxacilina/efeitos adversos , Cloxacilina/imunologia , Dessensibilização Imunológica/métodos , Hipersensibilidade a Drogas/imunologia , Endocardite Bacteriana/microbiologia , Feminino , Humanos , Penicilinas/efeitos adversos , Penicilinas/imunologia , Sepse/tratamento farmacológico , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/isolamento & purificaçãoRESUMO
BACKGROUND: Staphylococcus aureus bacteremia is associated with significant morbidity and mortality. To treat this infection, the current standard of care includes intravenous anti-staphylococcal beta-lactam antibiotics and obtaining adequate source control. Combination therapy with an aminoglycoside or rifampin, despite early promise, can no longer be routinely recommended due to an absence of proven benefit and risk of harm. Daptomycin is a rapidly acting bactericidal antibiotic that is approved for the treatment of Staphylococcus aureus bacteremia as monotherapy but has not been shown to be superior to the current standard of care. As demonstrated in vitro, the addition of daptomycin to beta-lactam therapy may result in enhanced anti-staphylococcal activity. Our objective is to assess the efficacy and safety of prescribing the combination of daptomycin with cefazolin or cloxacillin for the treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia in adults. We hypothesize that adjunctive therapy with daptomycin will reduce the duration of bacteremia in this population. METHODS: The DASH-RCT trial is a randomized, double blind, placebo-controlled trial designed per the Standard Protocol Items: Recommendation for Interventional Trials (SPIRIT) and Consolidated Standards of Reporting Trials (CONSORT) guidelines. We recruit adults with confirmed MSSA bacteremia, at the McGill University Health Center. Patients are eligible if they are 18 years or older, can receive cefazolin or cloxacillin monotherapy, and are enrolled within 72 h of the first blood culture being drawn. Exclusion criteria include anaphylaxis to study drugs, having polymicrobial bacteremia, anticipated hospital admission for < 5 days, and healthcare team refusal. While receiving standard of care, study patients are randomized to a 5-day course of adjunctive daptomycin or placebo. The trial began in December 2016 and is expected to end in December 2018, after recruiting an estimated 102 patients. DISCUSSION: The DASH-RCT will compare the use of daptomycin as an adjunct to an anti-staphylococcal beta-lactam versus placebo in the treatment of MSSA bacteremia. We believe that a short course of dual therapy will result in earlier eradication of bacteremia and that subsequent research could evaluate effects on metastatic infection, relapse, and/or mortality. Ongoing issues in the trial include a delay between presentation of infection, enrollment in the trial, and the potential for unrecognized deep foci of infection at diagnosis. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02972983 . Registered on 25 November 2016. Trial protocol: http://individual.utoronto.ca/leet/dash/dashprotocol.pdf.
Assuntos
Antibacterianos/administração & dosagem , Bacteriemia/tratamento farmacológico , Cefazolina/administração & dosagem , Cloxacilina/administração & dosagem , Daptomicina/administração & dosagem , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus/efeitos dos fármacos , Antibacterianos/efeitos adversos , Bacteriemia/diagnóstico , Bacteriemia/microbiologia , Cefazolina/efeitos adversos , Cloxacilina/efeitos adversos , Daptomicina/efeitos adversos , Método Duplo-Cego , Esquema de Medicação , Quimioterapia Combinada , Humanos , Estudos Multicêntricos como Assunto , Quebeque , Ensaios Clínicos Controlados Aleatórios como Assunto , Infecções Estafilocócicas/diagnóstico , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/patogenicidade , Fatores de Tempo , Resultado do TratamentoRESUMO
PURPOSE: To analyze the influence of adding gentamicin to a regimen consisting of ß-lactam or vancomycin plus rifampicin on survival in patients suffering from Staphylococcal prosthetic valve endocarditis (SPVE). METHODS: From January 2008 to September 2016, 334 patients with definite SPVE were attended in the participating hospitals. Ninety-four patients (28.1%) received treatment based on ß-lactam or vancomycin plus rifampicin and were included in the study. Variables were analyzed which related to patient survival during admission, including having received treatment with gentamicin. RESULTS: Seventy-seven (81.9%) were treated with cloxacillin (or vancomycin) plus rifampicin plus gentamicin, and 17 patients (18.1%) received the same regimen without gentamicin. The causative microorganism was Staphylococcus aureus in 40 cases (42.6%) and coagulase-negative staphylococci in 54 cases (57.4%). Overall, 40 patients (42.6%) died during hospital admission, 33 patients (42.9%) in the group receiving gentamicin and 7 patients in the group that did not (41.2%, P = 0.899). Worsening renal function was observed in 42 patients (54.5%) who received gentamicin and in 9 patients (52.9%) who did not (p = 0.904). Heart failure as a complication of endocarditis (OR: 4.58; CI 95%: 1.84-11.42) and not performing surgery when indicated (OR: 2.68; CI 95%: 1.03-6.94) increased mortality. Gentamicin administration remained unrelated to mortality (OR: 1.001; CI 95%: 0.29-3.38) in the multivariable analysis. CONCLUSIONS: The addition of gentamicin to a regimen containing vancomycin or cloxacillin plus rifampicin in SPVE was not associated to better outcome.
Assuntos
Antibacterianos/administração & dosagem , Endocardite Bacteriana/tratamento farmacológico , Endocardite Bacteriana/mortalidade , Gentamicinas/administração & dosagem , Próteses Valvulares Cardíacas/microbiologia , Infecções Relacionadas à Prótese/tratamento farmacológico , Infecções Relacionadas à Prótese/mortalidade , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/mortalidade , Idoso , Antibacterianos/uso terapêutico , Cloxacilina/administração & dosagem , Cloxacilina/uso terapêutico , Endocardite Bacteriana/complicações , Feminino , Gentamicinas/uso terapêutico , Insuficiência Cardíaca/induzido quimicamente , Insuficiência Cardíaca/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Estudos Prospectivos , Insuficiência Renal/induzido quimicamente , Insuficiência Renal/etiologia , Rifampina/administração & dosagem , Rifampina/uso terapêutico , Staphylococcus aureus/efeitos dos fármacos , Vancomicina/administração & dosagem , Vancomicina/uso terapêuticoRESUMO
Bovine mastitis affects the health of dairy cows and the profitability of herds worldwide. Coagulase-negative staphylococci (CNS) are the most frequently isolated pathogens in bovine intramammary infection. Based on the wide range of antimicrobial, mucoadhesive and immunostimulant properties demonstrated by chitosan, we have evaluated therapy efficiency of chitosan incorporation to cloxacillin antibiotic as well as its effect against different bacterial lifestyles of seven CNS isolates from chronic intramammary infections. The therapeutic effects of combinations were evaluated on planktonic cultures, bacterial biofilms and intracellular growth in mammary epithelial cells. We found that biofilms and intracellular growth forms offered a strong protection against antibiotic therapy. On the other hand, we found that chitosan addition to cloxacillin efficiently reduced the antibiotic concentration necessary for bacterial killing in different lifestyle. Remarkably, the combined treatment was not only able to inhibit bacterial biofilm establishment and increase preformed biofilm eradication, but it also reduced intracellular bacterial viability while it increased IL-6 secretion by infected epithelial cells. These findings provide a new approach to prophylactic drying therapy that could help to improve conventional antimicrobial treatment against different forms of bacterial growth in an efficient, safer and greener manner reducing multiresistant bacteria generation and spread.
Assuntos
Antibacterianos/uso terapêutico , Quitosana/uso terapêutico , Cloxacilina/uso terapêutico , Mastite Bovina/tratamento farmacológico , Infecções Estafilocócicas/veterinária , Staphylococcus/efeitos dos fármacos , Animais , Antibacterianos/administração & dosagem , Antibacterianos/farmacologia , Biofilmes/efeitos dos fármacos , Bovinos , Quitosana/administração & dosagem , Quitosana/farmacologia , Cloxacilina/administração & dosagem , Cloxacilina/farmacologia , Feminino , Mastite Bovina/microbiologia , Testes de Sensibilidade Microbiana , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/microbiologia , Staphylococcus/isolamento & purificação , Staphylococcus/fisiologiaRESUMO
Three hundred subclinically infected quarters of 259 Holstein cows infected with gram-positive bacteria were selected via quota sampling based on the California Mastitis Test (CMT) result and were divided randomly and equally into treatment and test groups. Quarters of test group (n = 150 in 128 cows) were treated with an intramammary infusion of tilmicosin, and quarters of the control group (n = 150 in 131 cows) were treated with cloxacillin as a traditional intramammary infusion of dry cow (DC) ointment. Cows with more than one infected quarter were randomly assigned to the same group, and adjacent quarters were treated the same. The milk samples of all quarters were obtained, and bacterial cultures and somatic cell count (SCC) were tested before dry cow therapy (DCT) (50 ± 15 days before parturition), and finally on day 2 of the next lactation. Results have shown that total bacteriological cure rates on day 2 of the next lactation were 45% and 78%, (p = .01), new infection rates were 43.3% and 56.6%, and SCC was (6.732 × 105 ± 3.124 × 105 ) and (5.025 × 105 ± 2.935 × 105 ), (p > .05) in test and control groups, respectively. Tilmicosin had less effect on reducing IMI due to Corynebacterium bovis, and had no effect on Streptococcus agalactiae, but had a potent effect against Staphylococcus aureus. It was concluded that tilmicosin alone should not be infused as an alternative to conventional dry cow therapy. However, it had a significant effect against S. aureus, and the potential of tilmicosin to treat S. aureus IMI should be confirmed in further studies.
Assuntos
Antibacterianos/uso terapêutico , Mastite Bovina/tratamento farmacológico , Tilosina/análogos & derivados , Animais , Antibacterianos/administração & dosagem , Infecções Assintomáticas , Bovinos , Contagem de Células/veterinária , Cloxacilina/administração & dosagem , Cloxacilina/uso terapêutico , Vias de Administração de Medicamentos/veterinária , Feminino , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Infecções por Bactérias Gram-Positivas/microbiologia , Infecções por Bactérias Gram-Positivas/veterinária , Glândulas Mamárias Animais , Mastite Bovina/microbiologia , Tilosina/administração & dosagem , Tilosina/uso terapêuticoRESUMO
AIM: To compare, in cows treated with an internal teat sealant, the effect of short-acting and long-acting cloxacillin-based dry-cow therapy on somatic cell counts (SCC) after calving. METHODS: Cows from a spring-calving, pasture-based dairy farm in the Manawatu-Whanganui region of New Zealand were randomly allocated to receive either a short-acting cloxacillin and ampicillin dry-cow therapy and internal teat sealant (n=291) or a long-acting cloxacillin and ampicillin dry-cow therapy and internal teat sealant (n=288) at the end of lactation. Cows were managed on-farm with routine husbandry procedures through the dry period and following calving. A multivariable logistic regression model was used to determine the association between length of action of dry-cow therapy and the proportion of cows with a SCC >150,000â cells/mL at the first herd test after calving. RESULTS: Age of cow, mean SCC for the preceding season and interval from calving to the first post-calving herd test were all associated with the proportion of cows with an individual SCC >150,000â cells/mL at the first herd test (p<0.001) Treatment with the short-acting dry-cow therapy was not associated with decreased odds of cows having a SCC >150,000â cells/mL at the first herd test compared with treatment with long-acting dry-cow therapy (OR=0.724; 95% CI=0.40-1.30). CONCLUSIONS AND CLINICAL RELEVANCE: In this herd, which routinely used internal teat sealants, the use of short-acting cloxacillin-based dry-cow therapy did not result in an increased proportion of cows with elevated SSC post-calving. This was a single farm, single year study but indicates that in this herd, changing from a long-acting to a short-acting antimicrobial may have no impact on the prevalence of subclinical mastitis.
Assuntos
Ampicilina/administração & dosagem , Antibacterianos/administração & dosagem , Cloxacilina/administração & dosagem , Glândulas Mamárias Animais/efeitos dos fármacos , Mastite Bovina/prevenção & controle , Animais , Bovinos/sangue , Contagem de Células , Indústria de Laticínios , Combinação de Medicamentos , Feminino , Modelos Logísticos , Nova Zelândia , Período Pós-Parto , Distribuição AleatóriaAssuntos
Falso Aneurisma/etiologia , Falso Aneurisma/terapia , Endocardite Bacteriana/microbiologia , Endocardite/complicações , Falso Aneurisma/diagnóstico por imagem , Angiografia/métodos , Antibacterianos/uso terapêutico , Cloxacilina/administração & dosagem , Cloxacilina/uso terapêutico , Síndromes Compartimentais/etiologia , Ecocardiografia Transesofagiana , Endocardite Bacteriana/complicações , Endocardite Bacteriana/diagnóstico por imagem , Endocardite Bacteriana/tratamento farmacológico , Procedimentos Endovasculares/métodos , Humanos , Masculino , Pessoa de Meia-Idade , Insuficiência da Valva Mitral/diagnóstico por imagem , Insuficiência da Valva Mitral/microbiologia , Insuficiência da Valva Mitral/cirurgia , Infecções Estafilocócicas/complicações , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/isolamento & purificação , Stents , Resultado do Tratamento , Ulna/irrigação sanguínea , Ulna/patologia , Artéria Ulnar/patologiaRESUMO
Introduction. The incidence of infective endocarditis is progressively increasing, especially in elderly patients. Outpatient parenteral antibiotic therapy (OPAT) is being an excellent alternative for treatment, but advanced age is one of the relative contraindications. The aim of this study is to compare the characteristics and prognosis of patients less or more than 80 years, treated with OPAT. Material and methods. One hundred and ninety four pa-tients were included between 1996 and 2015, 31 of them older than 80 years. Results. The most frequently affected valve is the aortic one, mainly native valves. Most used antibiotics are ceftriaxone, ampicillin, cloxacillin and daptomycin. Differences in surgery (39.9% vs 9.7%, p=0.001) and use of infusion pump (55.2% vs 35.5%; p= 0.044) were observed, under 80 years and older respectively. No differences in readmissions and mortality were observed. Conclusions. OPAT could be considered an effective alternative for appropriately-selected elderly patients with infective endocarditis (AU)
Introducción. La incidencia de la endocarditis infecciosa ha aumentado progresivamente, especialmente en pacientes de edad avanzada. La terapia antibiótica domiciliaria endovenosa (TADE) es una excelente alternativa de tratamiento, aunque la edad avanzada sea en algunas guías una contraindicación relativa. El objetivo de este estudio es comparar las características y el pronóstico de pacientes mayores y menores de 80 años tratados con TADE. Material y métodos. Fueron incluidos 194 pacientes entre los años 1996 y 2015, 31 de ellos con edades superiores a 80 años. Resultados. La válvula más frecuentemente afectada fue la aórtica, especialmente válvulas nativas. Los antibióticos más utilizados fueron la ceftriaxona, ampicilina, cloxacilina y daptomicina. Se observaron diferencias en cirugía (39,9% vs 9,7%, p=0,001) y en uso de bombas de infusión (55,2% vs 35,5%; p= 0,044), en los grupos menores y mayores de 80 años respectivamente. No se observaron diferencias significativas en reingresos y mortalidad. Conclusiones. La TADE podría considerarse una alternati-va adecuada en pacientes de edad avanzada con endocarditis infecciosa adecuadamente seleccionados (AU)
Assuntos
Humanos , Masculino , Feminino , Idoso de 80 Anos ou mais , Serviços de Assistência Domiciliar , Antibacterianos/administração & dosagem , Endocardite Bacteriana/complicações , Endocardite Bacteriana/tratamento farmacológico , Prognóstico , Ceftriaxona/administração & dosagem , Ampicilina/administração & dosagem , Cloxacilina/administração & dosagem , Daptomicina/administração & dosagemRESUMO
BACKGROUND: Treatment of community acquired skin and soft tissue infections (SSTIs) is a common indication for outpatient parenteral antibiotic therapy (OPAT) in USA, UK and Australasia, however data from Asia are lacking. OPAT is well established within the Singapore healthcare since 2002, however, systematic use of OPAT for the treatment of SSTIs remains infrequent. In this report, we describe the treatment and outcome of patients with SSTIs referred directly from Emergency Department (ED) to OPAT for continuation of intravenous (IV) antibiotics in Singapore, thus avoiding potential hospital admission. METHOD: This is a single center university hospital retrospective study of patients with SSTIs presenting to ED who were assessed to require IV antibiotics and accepted to the OPAT clinic for continuation of IV treatment. Exclusion criteria were: haemodynamic instability, uncontrolled or serious underlying co-morbidities, necessity for inpatient surgical drainage, facial cellulitis and cephalosporin allergy. Patients returned daily to the hospital's OPAT clinic for administration of IV antibiotics and review, then switched to oral antibiotics on improvement. RESULTS: From 7 February 2012 to 31 July 2015, 120 patients with SSTIs were treated in OPAT. Median age was 56 years and 63% were male. Lower limbs were affected in 91%. Diabetes was present in 20%. Sixty-seven (56%) had been treated with oral antibiotics for a median duration of 3 days prior to OPAT treatment. Common symptoms were erythema (100%), swelling (96%), pain (88%) and fever (55%). Antibiotics administered were IV cefazolin with oral probenecid (71%) or IV ceftriaxone (29%) for median 3 days then oral cloxacillin (85%) for median 7 days. Clinical improvement occurred in 90%. Twelve patients (10%) were hospitalized for worsening cellulitis, with 4 patients requiring surgical drainage of abscess. Microbiological cultures from 2 patients with drained abscess grew methicillin sensitive Staphylococcus aureus (MSSA) and Klebsiella pneumoniae, both of which were susceptible to cefazolin and ceftriaxone. Hospital bed days saved was 318 days. CONCLUSION: OPAT treatment of community acquired SSTIs in a selected patient population has good outcomes in Singapore. Treatment with IV cefazolin or IV ceftriaxone was successful in the majority with low hospital readmission rate.